89
Views
15
CrossRef citations to date
0
Altmetric
Review

Update on the sentinel lymph node procedure in vulvar cancer

, , &
Pages 61-69 | Published online: 10 Jan 2014

References

  • Booth H, Cooper N, Quinn M (Eds). Registration of Cancer Diagnosed in 2000, England. Office of National Statistics, Newport, Wales, UK.
  • US Cancer Statistics Working Group. United States Cancer Statistics: 2003 Incidence and Mortality. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, GA, USA (2006).
  • Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958–1996. Eur. J. Obstet. Gynecol. Reprod. Biol.101, 64–69 (2002).
  • Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol. Oncol.109, 340–345 (2008).
  • Joura EA, Lösch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasie. Increasing incidence of vulvar intraepithelial neoplasie and squamous cell carcinoma of the vulva in young women. J. Reprod. Med.45, 613–615 (2000).
  • Hacker NF. Vulvar cancer. In: Practical Gynecologic Oncology (Fourth edition). Berek JS, Hacker NF (Eds). Williams and Wilkins, PA, USA 543–583 (2005).
  • Homesley HD, Bundy BN, Sedlis A et al. Assessment of current International Federation of Gynecologic and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group Study). Am. J. Obstet. Gynecol.164(4), 997–1003 (1991).
  • Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol. Oncol.57(3), 327–334 (1995).
  • Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet. Gynecol.63(2), 155–162 (1984).
  • Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical–pathological variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol. Oncol.38(3), 309–314 (1990).
  • Hacker NF, van der Velden J. Conservative management of early vulvar cancer. Cancer71(4 Suppl.), 1673–1677 (1993).
  • De Hullu JA, Hollema H, Lolkema S et al. Vulvar carcinoma. The price of less radical surgery. Cancer95(11), 2331–2338 (2002).
  • Byron RL, Lamb EJ, Yonemoto RH, Kase S. Radical inguinal node dissection in the treatment of cancer. Surg. Gynecol. Obstet.114, 401–408 (1962).
  • Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate incisions. Obstet. Gynecol.58(5), 574–579 (1981).
  • Hopkins MP, Reid GC, Morley GW. Radical vulvectomy. The decision for the incision. Cancer72(3), 799–803 (1993).
  • Iversen T, Aas M. Lymph drainage from the vulva. Gynecol. Oncol.16(2), 179–183 (1983).
  • Burger MPM, Hollema H, Bouma J. The side of groin node metastases in unilateral vulvar carcinoma. Int. J. Gynecol. Cancer6, 318–322 (1996).
  • Barton DP. The prevention and management of treatment related morbidity in vulval cancer. Best Pract. Res. Clin. Obstet. Gynaecol.17(4), 683–701 (2003).
  • Oonk MH, Hollema H, de Hullu, van der Zee. Prediction of lymph node metastases in vulvar cancer: a review. Int. J. Gynecol. Cancer16(3), 963–971 (2006).
  • Gould EA, Winship T, Philbin PH, Kerr HH. Observation on a “sentinel node” in cancer of the parotid gland. Cancer13, 77–78 (1960).
  • Cabanas RM. An approach for the treatment of penile carcinoma. Cancer39(2), 456–466 (1977).
  • Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann. Surg.214(5), 637–641 (1991).
  • Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg.127(4), 392–399 (1992).
  • Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg. Oncol.2(3), 137–143 (1993).
  • Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med.349(6), 546–553 (2003).
  • Veronesi U, Paganelli G, Viale G et al. Sentinel-lymph-node biospy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol.7(12), 983–990 (2006).
  • Morton DL, Thompson JF, Cochran AJ et al. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med.355(13), 1307–1317 (2006).
  • Van der Zee AG, Oonk MH, de Hullu JA et al. Sentinel node detection is safe in the treatment of early-stage vulvar cancer. J. Clin. Oncol.26(6), 884–889 (2008).
  • Di Saia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am. J. Obstet. Gynecol.133(7), 825–832 (1979).
  • Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet. Gynecol.79(4), 490–497 (1992).
  • Gordinier ME, Malpica A, Burke TW et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol. Oncol.90(3), 625–628 (2003).
  • Stehman FB, Ali S, DiSaia PJ. Node count and groin recurrence in early vulvar cancer: a Gynecologic Oncology Group study. Gynecol. Oncol.113(1), 52–56 (2009).
  • Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet. Gynecol.84(2), 163–167 (1994).
  • Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol. Oncol.59(2), 216–220 (1995).
  • Decesare SL, Fiorica JV, Roberts et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol. Oncol.66(3), 425–428 (1997).
  • De Hullu JA, Doting E, Piers DA et al. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J. Nucl. Med.39(8), 1381–1385 (1998).
  • Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South. Med. J.92(2), 204–208 (1999).
  • Terada KY, Coel MN, Ko P, Wong JH. Combined use of intraoperative lymphatic mapping and lymphoscintigraphy in the management of squamous cell cancer of the vulva. Gynecol. Oncol.70(1), 65–69 (1998).
  • Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol. Oncol.76(1), 40–44 (2000).
  • Terada KY, Shimizu DM, Jiang CS, Wong JH. Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol. Oncol.102(2), 200–203 (2006).
  • Rodier JF, Janser JC, Routiot T et al. Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study. Oncol. Rep.6(6), 1249–1252 (1999).
  • Ansink AC, Sie-Go DM, van der Velden J et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer86(4), 652–656 (1999).
  • Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol. Oncol.83(2), 276–281 (2001).
  • De Cicco C, Sideri M, Bartolomei M et al. Sentinel node biopsy in early vulvar cancer. Br. J. Cancer.82(2), 295–299 (2000).
  • De Hullu JA, Hollema H, Piers DA et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J. Clin. Oncol.18(15), 2811–2816 (2000).
  • Hampl M, Hantschmann P, Michels W et al. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol. Oncol.111(2), 282–288 (2008).
  • Rob L, Robova H, Pluta M et al. Further data on sentinel lymph node mapping in vulvar cancer by blue dye and radiocolloid Tc99. Int. J. Gynecol. Cancer17(1), 147–153 (2007).
  • Sliutz G, Reinthaller A, Lantzsch T et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol. Oncol.84(3), 449–452 (2002).
  • Moore RG, DePasquale SE, Steinhoff MM et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol. Oncol.89(3), 475–479 (2003).
  • Merisio C, Berretta R, Gualdi M et al. Radioguided sentinel lymph node detection in vulvar cancer. Int. J. Gynecol. Cancer15(3), 493–497 (2005).
  • Puig-Tintoré LM, Ordi J, Vidal-Sicart S et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol. Oncol.88(1), 29–34 (2003).
  • Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A. Sentinel lymph node in vulvar cancer. Cancer110(5), 1015–1023 (2007).
  • Vidal-Sicart S, Puig-Tintoré LM, Lejárcequi JA et al. Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur. J. Nucl. Med. Mol. Imaging34(3), 384–391 (2007).
  • Nyberg RH, Iivonen M, Parkkinen J, Kuoppala T, Mäenpää JU. Sentinel node and vulvar cancer: a series of 47 patients. Acta Obstet. Gynecol. Scand.86(5), 615–619 (2007).
  • Moore RG, Robison K, Brown AK et al. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol. Oncol.109(1), 65–70 (2008).
  • Levenback CF, van der Zee AG, Rob L et al. Sentinel lymph node biopsy in patients with gynecologic cancers. Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol. Oncol.141, 151–156 (2009).
  • Brunner AH, Polterauer S, Tempfer C et al. The accuracy of intraoperative frozen section of the inguinal sentinel lymph node in vulvar cancer. Anticancer Res.28(6B), 4091–4094 (2008).
  • Asthana S, Deo SV, Shukla NK, Jain P, Anand M, Kumar R. Intraoperative neck staging using sentinel node biopsy and imprint cytology in oral cancer. Head Neck25(5), 368– 372 (2003).
  • Van Diest PJ, Torrenga H, Meijer S, Meijer CJ. Pathologic analysis of sentinel lymph nodes. Semin. Surg. Oncol.20(3), 238–245 (2001).
  • Knopp S, Holm R, Tropé C, Nesland JM. Occult lymph node metastases in early stage vulvar carcinoma patients. Gynecol. Oncol.99(2), 383–387 (2005).
  • Narayansingh GV, Miller ID, Sharma M et al. The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva. Br. J. Cancer92(2), 222–224 (2005).
  • Moore RG, Granai CO, Gajewski W, Gordinier M, Stienhoff MM. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol. Oncol.91(2), 378–382 (2003).
  • Kowalewska M, Radziszewski J, Kulik J et al. Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR. Int. J. Cancer116(6), 957–962 (2005).
  • Sobin LH, Wittekind Ch. TNM: Classification of Malignant Tumours (Sixth Edition). Wiley-Liss, NY, USA (2002).
  • Tamussino KF, Bader AA, Lax SF, Aigner RM, Winter R. Groin recurrence after micrometastasis in a sentinel lymph node in a patient with vulvar cancer. Gynecol. Oncol.86(1), 99–101 (2002).
  • Tjin-Asjoe FM, van Bekkum E, Ewing P, Burger CW, Ansink AC. Sentinel node procedure in vulvar squamous cell carcinoma: a histomorphologic review of 32 cases. The significance of anucleate structures on immunohistochemistry. Int. J. Gynecol. Cancer18(5), 1032–1036 (2008).
  • Gershenwald JE, Andtbacka RH, Prieto VG et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J. Clin. Oncol.26(26), 4296–4303 (2008).
  • Fons G, ter Rahe B, Sloof G, de Hullu J, van der Velden J. Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node. Gynecol. Oncol.92(3), 981–984 (2004).
  • De Hullu JA, Oonk MH, Ansink AC, Hollema H, Jager PL, van der Zee AG. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol. Oncol.94(1), 10–15 (2004).
  • Levavi H, Sabah G, Hardoff R, Koren C, Gutman H. Failure of sentinel node identification following neo-adjuvant chemo-radiotherapy for locally advances squamous cell carcinoma of the vulva. Eur. J. Gynaecol. Oncol.24(5); 433–434 (2003).
  • Fleissig A, Fallowfield LJ, Langridge CI et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res. Treat.95, 279–293 (2006).
  • Rietman JS, Geertzen JH, Hoekstra HJ et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy. Eur. J. Surg. Oncol.32, 148–152 (2006).
  • Oonk MH, van Os MA, de Bock GH, de Hullu JA, Ansink AC, van der Zee AG. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol. Oncol.113(3), 301–305 (2009).
  • Janda M, Obermair A, Cella D, Crandon AJ, Trimmel M. Vulvar cancer patients’ quality of life: a qualitative assessment. Int. J. Gynecol. Cancer14, 875–881 (2004).
  • Preti M, Ronco G, Ghiringhello B, Micheletti L. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. Cancer88, 1869–1876 (2000).
  • Maggino T, Landoni F, Sartori E et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva: a multicenter CTF study. Cancer86, 116–122 (2000).
  • Rouzier R, Haddad B, Plantier F, Dubois P, Pelisse M, Paniel BJ. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet. Gynecol.100, 1159–1167 (2002).
  • Woolderink JM, de Bock GH, de Hullu JA et al. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol. Oncol.103(1), 293–299 (2006).
  • De Hullu JA, Piers DA, Hollema H, Aalders JG, van der Zee AG. Sentinel lymph node detection in locally recurrent carcinoma of the vulva. Br. J. Obstet. Gynaecol.108, 766–768 (2001).
  • Landkroon AP, de Hullu JA, Ansink AC. Repeat sentinel lymph node procedure in vulval carcinoma. Br. J. Obstet. Gynaecol.113(11), 1333–1336 (2006).
  • Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlöf B, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival. Cancer86(7), 1285–1293 (1999).
  • De Hullu JA, Hollema H, Hoekstra HJ et al. Vulvar melanoma: is there a role for sentinel lymph node biospy? Cancer94(2), 486–491 (2002).
  • Abramova L, Parekh J, Irvin WP Jr et al. Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a review of literature. Ann. Surg. Oncol.9(9), 840–846 (2002).
  • Wechter ME, Gruber SB, Haefner HK et al. Vulvar melanoma: a report of 20 cases and a review of the literature. J. Am. Acad. Dermatol.50(4), 554–562 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.